FOXO1 and ovarian carcinoma: Li et al. indicated that KIF20A silencing significantly impaired the proliferative and invasive capabilities of ovarian cancer cells, and FOXO1 could target KIF20A to manipulate cellular behaviors (Li et al., 2020).